氣喘·COPD的全球市場:各藥物類型，各疾病類型，各流通管道，各地區-規模，佔有率，展望，機會分析(2022年～2028年)

本報告提供全球氣喘·COPD市場的相關調查，提供市場展望，市場動態，市場分析，競爭情形等全面性資訊。

目錄

第1章 調查目的·前提條件

• 調查目的
• 假設
• 簡稱

第2章 市場展望

• 報告的說明
  • 市場定義和範圍
• 摘要整理
  • 市場明細:各藥物類型
  • 市場明細:各疾病類型
  • 市場明細:各流通管道
• 連貫機遇地圖(COM)

第3章 市場動態，法規，及趨勢分析

• 市場動態
  • 促進因素
  • 阻礙因素
  • 市場機會
• 影響分析
• 主要的開發
• 法規方案
• PEST分析
• COVID-19影響分析

第4章 全球氣喘·COPD市場:各藥物類型(100萬美元)(2017年～2028年)

• 簡介
  • 市場佔有率分析(%)(2022年～2028年)
  • 與前一年同期比較成長分析(2017年～2028年)
  • 市場區隔趨勢
• 支氣管擴張藥
  • 簡介
  • 市場規模與預測，及與前一年同期比較成長率(100萬美元)(2017年～2028年)
  • 市場區隔趨勢
• 短效型支氣管擴張藥
• 長效型支氣管擴張藥
• 抗膽鹼促效劑
• 抗發炎劑
  • 簡介
  • 市場規模與預測，及與前一年同期比較成長率(100萬美元)(2017年～2028年)
  • 市場區隔趨勢
• 吸入皮質類固醇
• 抗白三烯
• 單株抗體
• 聯合治療
  • 簡介
  • 市場規模與預測，及與前一年同期比較成長率(100萬美元)(2017年～2028年)
  • 市場區隔趨勢

第5章 全球氣喘·COPD市場:各疾病類型(100萬美元)(2017年～2028年)

• 簡介
  • 市場佔有率分析(%)(2022年～2028年)
  • 與前一年同期比較成長分析(2017年～2028年)
  • 市場區隔趨勢
• 氣喘
  • 簡介
  • 市場規模與預測，及與前一年同期比較成長率(100萬美元)(2017年～2028年)
• COPD
  • 簡介
  • 市場規模與預測，及與前一年同期比較成長率(100萬美元)(2017年～2028年)

第6章 全球氣喘·COPD市場:各流通管道(100萬美元)(2017年～2028年)

• 簡介
  • 市場佔有率分析(%)(2022年～2028年)
  • 與前一年同期比較成長分析(2017年～2028年)
  • 市場區隔趨勢
• 醫院藥局
  • 簡介
  • 市場規模與預測，及與前一年同期比較成長率(100萬美元)(2017年～2028年)
• 零售藥局
  • 簡介
  • 市場規模與預測，及與前一年同期比較成長率(100萬美元)(2017年～2028年)
• 線上藥局
  • 簡介
  • 市場規模與預測，及與前一年同期比較成長率(100萬美元)(2017年～2028年)
• 藥妝店
  • 簡介
  • 市場規模與預測，及與前一年同期比較成長率(100萬美元)(2017年～2028年)

第7章 全球氣喘·COPD市場:各地區(100萬美元)(2017年～2028年)

• 簡介
  • 市場佔有率分析(%)(2022年～2028年)
  • 與前一年同期比較成長分析(2017年～2028年)
  • 市場區隔趨勢
• 北美
• 美國
• 加拿大
• 歐洲
• 英國
• 德國
• 義大利
• 法國
• 西班牙
• 俄羅斯
• 其他的歐洲
• 亞太地區
• 中國
• 印度
• 日本
• 東南亞國協
• 澳洲
• 韓國
• 其他的亞太地區
• 南美
• 巴西
• 墨西哥
• 阿根廷
• 其他的南美
• 中東
• GCC各國
• 以色列
• 其他的中東
• 非洲
• 北非
• 中非
• 南非

第8章 競爭情形

• 企業簡介
• AstraZeneca PLC
• Novartis AG
• GlaxoSmithKline plc
• Merck &Co., Inc.
• Verona Pharma plc
• Regeneron Pharmaceuticals, Inc.
• Boehringer Ingelheim GmbH

第9章 章節

• 參考文獻
• 調查手法
• 關於本公司和營業窗口

Asthma is a type of chronic respiratory disease, which is characterized by attacks of breathlessness and wheezing. Asthma can occur at any stage, though it is the most common disease in children. Asthma attacks are linked to respiratory infections and environmental factors such as allergens, tobacco, smoke, and indoor and outdoor pollution. Indoor pollution factors include mold, chemicals, strong odors, and house dust whereas outdoor pollution factors include air pollution, allergens, tobacco, and smoking. Such factors are responsible for development and exacerbation of asthma.

Restraints of the Global Asthma and COPD Market

Major factors hampering the growth of the asthma and COPD market during the forecast period constitutes of patent losses, and high costs.

Key features of the study:

• This report provides in-depth analysis of the global asthma and COPD market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global asthma and COPD market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include AstraZeneca, Novartis AG, GlaxoSmithKline plc, Merck & Co., Verona Pharma plc,, Regeneron Pharmaceuticals, Inc., GlaxoSmithKline plc, and Boehringer Ingelheim GmbH.
• Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• The global asthma and COPD market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

• Global Asthma and COPD Market, By Drug Type:
  • Bronchodilators
• Short Acting Bronchodilators
• Long Acting Bronchodilators
• Anticholinergics
  • Anti-Inflammatories
• Inhaled Corticosteroids
• Anti-Leukotriene
• Monoclonal Antibodies
  • Combination Therapies
• Global Asthma and COPD Market, By Disease Type:
  • Asthma
  • COPD
• Global Asthma and COPD Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores
• Global Asthma and COPD Market, By Geography:
  • North America
• By Drug Type
  • Bronchodilators
    • Short Acting Bronchodilators
    • Long Acting Bronchodilators
    • Anticholinergics
  • Anti-Inflammatories
    • Inhaled Corticosteroids
    • Anti-Leukotriene
    • Monoclonal Antibodies
  • Combination Therapies
• By Disease Type
  • Asthma
  • COPD
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores
• By Country:
  • U.S.
  • Canada
  • Europe
• By Drug Type
  • Bronchodilators
    • Short Acting Bronchodilators
    • Long Acting Bronchodilators
    • Anticholinergics
  • Anti-Inflammatories
    • Inhaled Corticosteroids
    • Anti-Leukotriene
    • Monoclonal Antibodies
  • Combination Therapies
• By Disease Type
  • Asthma
  • COPD
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores
• By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
• By Drug Type
  • Bronchodilators
    • Short Acting Bronchodilators
    • Long Acting Bronchodilators
    • Anticholinergics
  • Anti-Inflammatories
    • Inhaled Corticosteroids
    • Anti-Leukotriene
    • Monoclonal Antibodies
  • Combination Therapies
• By Disease Type
  • Asthma
  • COPD
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores
• By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
• By Drug Type
  • Bronchodilators
    • Short Acting Bronchodilators
    • Long Acting Bronchodilators
    • Anticholinergics
  • Anti-Inflammatories
    • Inhaled Corticosteroids
    • Anti-Leukotriene
    • Monoclonal Antibodies
  • Combination Therapies
• By Disease Type
  • Asthma
  • COPD
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores
• By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East:
• By Drug Type
  • Bronchodilators
    • Short Acting Bronchodilators
    • Long Acting Bronchodilators
    • Anticholinergics
  • Anti-Inflammatories
    • Inhaled Corticosteroids
    • Anti-Leukotriene
    • Monoclonal Antibodies
  • Combination Therapies
• By Disease Type
  • Asthma
  • COPD
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores
• By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
• By Drug Type
  • Bronchodilators
    • Short Acting Bronchodilators
    • Long Acting Bronchodilators
    • Anticholinergics
  • Anti-Inflammatories
    • Inhaled Corticosteroids
    • Anti-Leukotriene
    • Monoclonal Antibodies
  • Combination Therapies
• By Disease Type
  • Asthma
  • COPD
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores
• By Country/Region:
  • Central Africa
  • South Africa
  • North Africa
• Company Profiles
  • AstraZeneca PLC*
• Company Overview
• Product Portfolio
• Financial Performance
• Key Strategies
• Recent Developments
  • Novartis AG
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Verona Pharma plc
  • Regeneron Pharmaceuticals, Inc.
  • Boehringer Ingelheim GmbH

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
• Market Definition and Scope
  • Executive Summary
• Market Snippet, By Drug Type
• Market Snippet, By Disease Type
• Market Snippet, By Distribution Channel
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• Market Opportunities
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • PEST Analysis
  • COVID-19 Impact Analysis

4. Global Asthma and COPD Market, By Drug Type, 2017 - 2028 (US$ Mn)

• Introduction
• Market Share Analysis, 2022 and 2028 (%)
• Y-o-Y Growth Analysis, 2017 - 2028
• Segment Trends
  • Bronchodilators
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Segment Trends
  • Short Acting Bronchodilators
  • Long Acting Bronchodilators
  • Anticholinergics
  • Anti-Inflammatories
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Segment Trends
  • Inhaled Corticosteroids
  • Anti-Leukotriene
  • Monoclonal Antibodies
  • Combination Therapies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Segment Trends

5. Global Asthma and COPD Market, By Disease Type, 2017 - 2028 (US$ Mn)

• Introduction
• Market Share Analysis, 2022 and 2028 (%)
• Y-o-Y Growth Analysis, 2017 - 2028
• Segment Trends
  • Asthma
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • COPD
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Asthma and COPD Market, By Distribution Channel, 2017 - 2028 (US$ Mn)

• Introduction
• Market Share Analysis, 2022 and 2028 (%)
• Y-o-Y Growth Analysis, 2017 - 2028
• Segment Trends
  • Hospital Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Retail Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Online Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Drug Stores
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Asthma and COPD Market, By Regions, 2017 - 2028 (US$ Mn)

• Introduction
• Market Share Analysis, 2022 and 2028 (%)
• Y-o-Y Growth Analysis, 2017 - 2028
• Segment Trends
  • North America
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • U.S.
  • Canada
  • Europe
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

8. Competitive Landscape

• Company Profiles
• AstraZeneca PLC
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novartis AG
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GlaxoSmithKline plc
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck & Co., Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Verona Pharma plc
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Regeneron Pharmaceuticals, Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Boehringer Ingelheim GmbH
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

9. Section

• References
• Research Methodology
• About us and Sales Contact